Bio-Responsive nanoparticle for tumor targeting and enhanced photo-immunotherapy

Despite the potential of immunotherapy in various solid tumors, the efficiency of immunotherapy is limited by little tumor-infiltrating lymphocytes (TILs) and abundant immunosuppressive M2-type tumor-associated macrophages (M2-TAMs) in the tumor microenvironment (TME). Herein, we design a versatile photoimmunotherapy nanoparticle (termed as HA-AuNR/M-M2pep NP) to conquer above challenges. The HAAuNR/M-M2pep NP is composed of hyaluronic acid modified gold nanorod (HA-AuNR) surface-modified with matrix metalloproteinase-2 (MMP2)-responsive M2pep fusion peptides (M-M2pep). Upon tumor site, the fabricated HA-AuNR/M-M2pep NP releases M2pep through the cleavage of MMP2-sensitive peptide to selectively deplete M2-TAMs and improve immunoactivity of TME. Meanwhile, HA-AuNR could target to tumor cells and realize precise tumor photothermal therapy (PTT) under near infrared light irradiation, which further triggers immunogenic cell death (ICD) of tumor cells and elicits antitumor immunity. In vivo antitumor studies reveal that HA-AuNR/M-M2pep NPs-mediated PTT and M2-TAMs depletion recruit TILs, activate effector T lymphocytes, secrete antitumor cytokines (e.g. IFN-gamma, TNF-alpha), and effectively inhibit the growth of tumor. Collectively, HAAuNR/M-M2pep NP-mediated photo-immunotherapy based on dual targeted delivery and bio-responsive drug release holds tremendous promise to enhance antitumor efficacy.

Automated summary

A versatile photoimmunotherapy nanoparticle was designed to selectively deplete immunosuppressive tumor-associated macrophages and enhance immunity within the tumor microenvironment. The nanoparticle achieved precise tumor photothermal therapy and induced immunogenic cell death, leading to activation of antitumor immune responses.